Iconic Therapeutics is a clinical stage biopharmaceutical company dedicated to translating scientific insight into breakthrough medicines. Our deep understanding of the role of Tissue Factor in angiogenesis, inflammation and malignancies has led us to a new approach to developing therapies for devastating diseases such as macular degeneration and cancer. Our highly experienced management team is brought together by a shared commitment to working with passion, changing medicine and building an outstanding company. We partner with world-renowned researchers, preeminent clinicians and key advocacy groups to advance our programs. Iconic is backed by top tier life science investors and is guided by an outstanding Board of Directors comprised of biotechnology industry leaders.
View Top Employees from Iconic Therapeutics, Inc.Website | http://www.iconictherapeutics.com |
Revenue | $8 million |
Funding | $38.4 million |
Employees | 8 (2 on RocketReach) |
Founded | 2002 |
Address | 701 Gateway Blvd, Ste 100, South San Francisco, California 94080, US |
Phone | (650) 437-1000 |
Fax | (650) 246-9011 |
Technologies |
JavaScript,
HTML,
PHP
+16 more
(view full list)
|
Category | Biotechnology, Pharmaceuticals, Biopharma, Healthcare, Health Care, Science and Engineering, Therapeutics |
Competitors | ARMO BioSciences, Amplyx, now a subsidiary of Pfizer Inc., NGM Biopharmaceuticals, SCYNEXIS, Inc., VTV |
SIC | 873, 87 |
NAICS | 541, 54171, 541714, 54, 5417 |
Looking for a particular Iconic Therapeutics, Inc. employee's phone or email?
The Iconic Therapeutics, Inc. annual revenue was $8 million in 2023.
Cynthia Porter is the Vice President, Development Operations of Iconic Therapeutics, Inc..
2 people are employed at Iconic Therapeutics, Inc..
Iconic Therapeutics, Inc. is based in South San Francisco, California.
The NAICS codes for Iconic Therapeutics, Inc. are [541, 54171, 541714, 54, 5417].
The SIC codes for Iconic Therapeutics, Inc. are [873, 87].